iTeos Therapeutics (ITOS)
US Market

iTeos Therapeutics (ITOS) Stock Price & Analysis


ITOS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$12.52 - $35.64
Previous Close$13.93
Average Volume (3M)280.99K
Market Cap
Enterprise Value-$110.90M
Total Cash (Recent Filing)$613.16M
Total Debt (Recent Filing)$4.67M
Price to Earnings (P/E)5.5
May 11, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.54
Shares Outstanding35,720,401
10 Day Avg. Volume337,093
30 Day Avg. Volume280,987
Standard Deviation0.20
Financial Highlights & Ratios
Price to Book (P/B)0.73
Price to Sales (P/S)1.86
Price to Cash Flow (P/CF)1.70
P/FCF Ratio-4.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.41
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda-0.85
Price Target Upside200.76% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was iTeos Therapeutics’s price range in the past 12 months?
iTeos Therapeutics lowest stock price was $12.52 and its highest was $35.64 in the past 12 months.
    What is iTeos Therapeutics’s market cap?
    Currently, no data Available
    When is iTeos Therapeutics’s upcoming earnings report date?
    iTeos Therapeutics’s upcoming earnings report date is May 11, 2023 which is in 41 days.
      How were iTeos Therapeutics’s earnings last quarter?
      iTeos Therapeutics released its earnings results on Mar 15, 2023. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.235 by $0.325.
        Is iTeos Therapeutics overvalued?
        According to Wall Street analysts iTeos Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does iTeos Therapeutics pay dividends?
          iTeos Therapeutics does not currently pay dividends.
          What is iTeos Therapeutics’s EPS estimate?
          iTeos Therapeutics’s EPS estimate is -$0.81.
            How many shares outstanding does iTeos Therapeutics have?
            iTeos Therapeutics has 35,720,400 shares outstanding.
              What happened to iTeos Therapeutics’s price movement after its last earnings report?
              iTeos Therapeutics reported an EPS of $0.56 in its last earnings report, beating expectations of $0.235. Following the earnings report the stock price went down -1.749%.
                Which hedge fund is a major shareholder of iTeos Therapeutics?
                Among the largest hedge funds holding iTeos Therapeutics’s share is RA Capital Management. It holds iTeos Therapeutics’s shares valued at 86M.


                  iTeos Therapeutics Stock Smart Score

                  The iTeos Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  iTeos Therapeutics

                  ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody.


                  Top 5 ETFs holding ITOS

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold ITOS. The ETFs are listed according to market value of ITOS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  PureTech Health
                  4D Molecular Therapeutics
                  CTI BioPharma
                  POINT Biopharma Global
                  Anavex Life Sciences

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis